...incremental but continuing government incursion into an industry that has defined extraordinary results....Government almost never gives power back, and in this instance we expect nothing more than a continuing slide from the industry’s current heights.”
— Numerof & Associates President Rita Numerof, Ph.D., talked
with AIS’s Radar on Drug Benefits about the Build Back Better Act’s
controversial drug pricing reform efforts.
No comments:
Post a Comment